Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free KSI Stock Alerts

kneat.com (KSI) Competitors

kneat.com logo
C$5.28 +0.18 (+3.53%)
As of 05/25/2026 04:00 PM Eastern
Compare

KSI vs. VHI, CARE, RHT, ADK, and DOC

Should you buy kneat.com stock or one of its competitors? MarketBeat compares kneat.com with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with kneat.com include Vitalhub (VHI), Dialogue Health Technologies (CARE), Reliq Health Technologies (RHT), DIAGNOS (ADK), and CloudMD Software & Services (DOC). These companies are all part of the "health information services" industry.

How does kneat.com compare to Vitalhub?

kneat.com (TSE:KSI) and Vitalhub (TSE:VHI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

4.8% of kneat.com shares are held by institutional investors. Comparatively, 26.7% of Vitalhub shares are held by institutional investors. 26.0% of kneat.com shares are held by insiders. Comparatively, 18.6% of Vitalhub shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

kneat.com currently has a consensus target price of C$6.25, suggesting a potential upside of 18.37%. Vitalhub has a consensus target price of C$13.86, suggesting a potential upside of 92.19%. Given Vitalhub's higher possible upside, analysts clearly believe Vitalhub is more favorable than kneat.com.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
kneat.com
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14

Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
kneat.comC$66.52M7.63-C$8.62M-C$0.08N/A
VitalhubC$119.20M3.83C$3.35MC$0.1260.08

In the previous week, kneat.com had 1 more articles in the media than Vitalhub. MarketBeat recorded 1 mentions for kneat.com and 0 mentions for Vitalhub. kneat.com's average media sentiment score of 0.00 equaled Vitalhub'saverage media sentiment score.

Company Overall Sentiment
kneat.com Neutral
Vitalhub Neutral

Vitalhub has a net margin of 6.13% compared to kneat.com's net margin of -12.69%. Vitalhub's return on equity of 2.98% beat kneat.com's return on equity.

Company Net Margins Return on Equity Return on Assets
kneat.com-12.69% -12.95% -9.84%
Vitalhub 6.13%2.98%3.81%

kneat.com has a beta of 0.861672, meaning that its stock price is 14% less volatile than the broader market. Comparatively, Vitalhub has a beta of 0.866895, meaning that its stock price is 13% less volatile than the broader market.

Summary

Vitalhub beats kneat.com on 11 of the 15 factors compared between the two stocks.

How does kneat.com compare to Dialogue Health Technologies?

Dialogue Health Technologies (TSE:CARE) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

kneat.com has a net margin of -12.69% compared to Dialogue Health Technologies' net margin of -19.73%. kneat.com's return on equity of -12.95% beat Dialogue Health Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Dialogue Health Technologies-19.73% -19.76% -10.01%
kneat.com -12.69%-12.95%-9.84%

47.0% of Dialogue Health Technologies shares are held by institutional investors. Comparatively, 4.8% of kneat.com shares are held by institutional investors. 11.7% of Dialogue Health Technologies shares are held by insiders. Comparatively, 26.0% of kneat.com shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

kneat.com has lower revenue, but higher earnings than Dialogue Health Technologies. kneat.com is trading at a lower price-to-earnings ratio than Dialogue Health Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dialogue Health TechnologiesC$95.88M0.00-C$19.50M-C$0.30N/A
kneat.comC$66.52M7.63-C$8.62M-C$0.08N/A

Dialogue Health Technologies has a beta of 2.66, suggesting that its stock price is 166% more volatile than the broader market. Comparatively, kneat.com has a beta of 0.861672, suggesting that its stock price is 14% less volatile than the broader market.

In the previous week, kneat.com had 1 more articles in the media than Dialogue Health Technologies. MarketBeat recorded 1 mentions for kneat.com and 0 mentions for Dialogue Health Technologies. Dialogue Health Technologies' average media sentiment score of 0.00 equaled kneat.com'saverage media sentiment score.

Company Overall Sentiment
Dialogue Health Technologies Neutral
kneat.com Neutral

kneat.com has a consensus target price of C$6.25, suggesting a potential upside of 18.37%. Given kneat.com's stronger consensus rating and higher possible upside, analysts plainly believe kneat.com is more favorable than Dialogue Health Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dialogue Health Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
kneat.com
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

Summary

kneat.com beats Dialogue Health Technologies on 11 of the 15 factors compared between the two stocks.

How does kneat.com compare to Reliq Health Technologies?

Reliq Health Technologies (CVE:RHT) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings.

2.8% of Reliq Health Technologies shares are held by institutional investors. Comparatively, 4.8% of kneat.com shares are held by institutional investors. 1.8% of Reliq Health Technologies shares are held by company insiders. Comparatively, 26.0% of kneat.com shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, kneat.com had 1 more articles in the media than Reliq Health Technologies. MarketBeat recorded 1 mentions for kneat.com and 0 mentions for Reliq Health Technologies. Reliq Health Technologies' average media sentiment score of 0.00 equaled kneat.com'saverage media sentiment score.

Company Overall Sentiment
Reliq Health Technologies Neutral
kneat.com Neutral

Reliq Health Technologies has a beta of 1.64, meaning that its stock price is 64% more volatile than the broader market. Comparatively, kneat.com has a beta of 0.861672, meaning that its stock price is 14% less volatile than the broader market.

Reliq Health Technologies has higher earnings, but lower revenue than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Reliq Health Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Reliq Health TechnologiesN/AN/AN/A-C$0.02N/A
kneat.comC$66.52M7.63-C$8.62M-C$0.08N/A

kneat.com has a net margin of -12.69% compared to Reliq Health Technologies' net margin of -95.54%. kneat.com's return on equity of -12.95% beat Reliq Health Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Reliq Health Technologies-95.54% -221.64% -5.30%
kneat.com -12.69%-12.95%-9.84%

kneat.com has a consensus price target of C$6.25, suggesting a potential upside of 18.37%. Given kneat.com's stronger consensus rating and higher possible upside, analysts plainly believe kneat.com is more favorable than Reliq Health Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Reliq Health Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
kneat.com
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

Summary

kneat.com beats Reliq Health Technologies on 10 of the 14 factors compared between the two stocks.

How does kneat.com compare to DIAGNOS?

DIAGNOS (CVE:ADK) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

kneat.com has a net margin of -12.69% compared to DIAGNOS's net margin of -6,907.32%. DIAGNOS's return on equity of 3,086.87% beat kneat.com's return on equity.

Company Net Margins Return on Equity Return on Assets
DIAGNOS-6,907.32% 3,086.87% -134.33%
kneat.com -12.69%-12.95%-9.84%

0.3% of DIAGNOS shares are owned by institutional investors. Comparatively, 4.8% of kneat.com shares are owned by institutional investors. 16.8% of DIAGNOS shares are owned by insiders. Comparatively, 26.0% of kneat.com shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

DIAGNOS has a beta of 0.173588, indicating that its share price is 83% less volatile than the broader market. Comparatively, kneat.com has a beta of 0.861672, indicating that its share price is 14% less volatile than the broader market.

DIAGNOS has higher earnings, but lower revenue than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than DIAGNOS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DIAGNOSC$68.16K283.95-C$3.81M-C$0.05N/A
kneat.comC$66.52M7.63-C$8.62M-C$0.08N/A

In the previous week, kneat.com had 1 more articles in the media than DIAGNOS. MarketBeat recorded 1 mentions for kneat.com and 0 mentions for DIAGNOS. DIAGNOS's average media sentiment score of 0.00 equaled kneat.com'saverage media sentiment score.

Company Overall Sentiment
DIAGNOS Neutral
kneat.com Neutral

kneat.com has a consensus target price of C$6.25, suggesting a potential upside of 18.37%. Given kneat.com's stronger consensus rating and higher possible upside, analysts plainly believe kneat.com is more favorable than DIAGNOS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DIAGNOS
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
kneat.com
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

Summary

kneat.com beats DIAGNOS on 11 of the 16 factors compared between the two stocks.

How does kneat.com compare to CloudMD Software & Services?

kneat.com (TSE:KSI) and CloudMD Software & Services (CVE:DOC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

kneat.com currently has a consensus price target of C$6.25, suggesting a potential upside of 18.37%. Given kneat.com's stronger consensus rating and higher probable upside, equities research analysts plainly believe kneat.com is more favorable than CloudMD Software & Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
kneat.com
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25
CloudMD Software & Services
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

4.8% of kneat.com shares are held by institutional investors. Comparatively, 0.5% of CloudMD Software & Services shares are held by institutional investors. 26.0% of kneat.com shares are held by insiders. Comparatively, 0.1% of CloudMD Software & Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

kneat.com has higher earnings, but lower revenue than CloudMD Software & Services. kneat.com is trading at a lower price-to-earnings ratio than CloudMD Software & Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
kneat.comC$66.52M7.63-C$8.62M-C$0.08N/A
CloudMD Software & ServicesC$90.91M0.12-C$76.56M-C$0.23N/A

In the previous week, kneat.com had 1 more articles in the media than CloudMD Software & Services. MarketBeat recorded 1 mentions for kneat.com and 0 mentions for CloudMD Software & Services. kneat.com's average media sentiment score of 0.00 equaled CloudMD Software & Services'average media sentiment score.

Company Overall Sentiment
kneat.com Neutral
CloudMD Software & Services Neutral

kneat.com has a beta of 0.861672, meaning that its share price is 14% less volatile than the broader market. Comparatively, CloudMD Software & Services has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

kneat.com has a net margin of -12.69% compared to CloudMD Software & Services' net margin of -91.12%. kneat.com's return on equity of -12.95% beat CloudMD Software & Services' return on equity.

Company Net Margins Return on Equity Return on Assets
kneat.com-12.69% -12.95% -9.84%
CloudMD Software & Services -91.12%-102.91%-8.74%

Summary

kneat.com beats CloudMD Software & Services on 12 of the 16 factors compared between the two stocks.

Get kneat.com News Delivered to You Automatically

Sign up to receive the latest news and ratings for KSI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KSI vs. The Competition

Export
Metrickneat.comHealth Information Services IndustryMedical SectorTSE Exchange
Market CapC$507.58MC$322.71MC$6.46BC$12.16B
Dividend YieldN/A5.60%2.76%6.20%
P/E Ratio-66.00195.2121.2237.64
Price / Sales7.63128.40562.2811.68
Price / Cash13.1847.1443.4982.29
Price / Book8.025.3610.314.50
Net Income-C$8.62M-C$22.78MC$3.57BC$299.09M
7 Day Performance5.60%3.09%6.43%2.48%
1 Month Performance19.46%-0.78%3.57%1.47%
1 Year Performance-17.24%-11.56%34.07%53.55%

kneat.com Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KSI
kneat.com
1.3441 of 5 stars		C$5.28
+3.5%		C$6.25
+18.4%		-18.5%C$507.58MC$66.52MN/A293
VHI
Vitalhub
2.9587 of 5 stars		C$7.13
+0.6%		C$13.86
+94.3%		-29.0%C$451.04MC$119.20M59.422,250
CARE
Dialogue Health Technologies
N/AN/AN/AN/AC$345.36MC$95.88MN/A730
RHT
Reliq Health Technologies
N/AC$0.22
flat		N/A+0.0%C$46.65MN/AN/A12,600
ADK
DIAGNOS
N/AC$0.19
-5.0%		N/A-19.1%C$22.66MC$68.16KN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:KSI) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
The S-1 just dropped. 22 days left.
The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...
Behind the Markets | Sponsoredtc pixel
My crisis of conscience
Emmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...
Eagle Publishing | Sponsoredtc pixel